Predicting neuroblastoma spread risk
Part of Cancer clinical trials.
This trial uses a risk model to help detect if neuroblastoma has spread to the bone or bone marrow in newly diagnosed patients. It aims to improve how doctors identify metastasis without needing extra special tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with neuroblastoma (a type of childhood cancer).
- Your diagnosis has been confirmed by a specialist using imaging and lab tests.
- You have not yet started chemotherapy or radiation therapy.
- You have had a bone marrow smear test (a sample of bone marrow taken and stained) already done as part of routine care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of targeted radiation treatment for children and adults with neuroblastoma that has come back or not responded to other treatments. The radiation is attached to a substance that seeks out neuroblastoma cells, aiming to destroy them while limiting harm to healthy tissue.
This study looks at people with cancer that has spread to the bones. It uses your medical imaging and records to understand your risk of bone fracture, without testing any new treatment.
This trial tests if a special imaging analysis can predict where your cancer might spread. It's for people with advanced lung, colorectal, or breast cancer who are starting or continuing treatment.
This study looks at how high-risk neuroblastoma grows and behaves by collecting samples from your child and checking disease markers. It may help researchers understand what biology is driving the cancer and guide future treatments.
This study tests a model that predicts the risk of breast cancer spreading to the brain. It looks at women with hormone receptor positive breast cancer to help doctors better identify who might need closer monitoring.
This study uses information from women with newly diagnosed breast cancer that has spread (metastatic) to create a tool that helps predict how the disease may progress. By looking at your medical records, they hope to improve care and help future patients.
Hear when a new Neuroblastoma (NB) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.